BTIG Research

In a report published Friday, BTIG Research analyst Dane Leone initiated coverage on Illumina, Inc. (NASDAQ: ILMN) with a Buy rating and $220.00 price target. In the report, BTIG Research noted, “We think ILMN is a good investment for long‐term investors as opportunities in the clinical diagnostics...

In a report published Friday, BTIG Research analyst Dane Leone initiated coverage on Alere Inc (NYSE: ALR) with a Buy rating and $48.00 price target. In the report, BTIG Research noted, “Under the assumption that ALR operates as an independent entity over the next several years, we think the new...

Analysts at BTIG Equity Research initiated coverage on Lombard Medical Inc (NASDAQ: EVAR) with a Buy rating and $9 price target Thursday. Sean Lavin highlighted drivers for the firm: The company's innovative Aorfix Stent graft has two significant opportunities. It is the only FDA label...

Analysts at BTIG Research upgraded Endologix (NASDAQ: ELGX) from Neutral to Buy. The target price for Endologix is set to $17. Endologix shares have dropped 17.30% over the past 52 weeks, while the S&P 500 index has surged 20.02% in the same period. Endologix's shares surged 2.93% to $13.68...

As Netflix's (NASDAQ: NFLX) stock broke the $400 mark in February, BTIG published a blog regarding the implied value of HBO relative to the market value of Netflix. The question raised by the blog was does it make sense for HBO to be valued around $26 billion as part of Time Warner (NYSE:...

Analysts at BTIG Research initiated coverage on shares of Clorox Company (The) (NYSE: CLX) with a Neutral rating. The target price for Clorox Company is set to $92. Colfax shares have gained 5.77% over the past 52 weeks, while the S&P 500 index has surged 15.91% in the same period. Clorox's...

In blog post published Wednesday, BTIG analyst Richard Greenfield downgraded shares of Viacom (NASDAQ: VIAB) and Discovery Communications (NASDAQ: DISCA) and removed his price target on both companies. Greenfield updated his model and provided the following EPS estimates: Viacom EPS: 2014E...

In a note dated June 18, BTIG analyst Theo Brito initiated coverage on Monster Beverage (NASDAQ: MNST) with a Buy rating and announced a $90 price target. Brito wrote, "We believe the market is overly pessimistic about prospects for the energy sector and for Monster's potential in...

In a note date June 18, BTIG analyst Theo Brito initiated coverage on Keurig Green Mountain (NASDAQ: GMCR) with a Neutral rating and announced a $124 price target. Market Penetration Brito is taking a cautious to slightly bearish position on Keurig. He began his coverage by noting he believes...

Various media sources reported on Thursday that Apple (NASDAQ: AAPL) would be interested in acquiring Beats Electronics, the popular headphone maker and music streaming distributor, for $3.2 billion. Beats Electronics was founded by rapper and hip-hop producer-turned-businessman Dr. Dre and...

In a report published Thursday, BTIG Research analyst Sean Lavin initiated coverage on Hologic Inc. (NASDAQ: HOLX) with a Buy rating and $26.00 price target. Lavin noted four main reasons to buy this mid cap med tech company. The analyst first emphasized that earnings growth is "almost automatic...

In a report published Friday, BTIG Research analyst Sean Lavin initiated coverage on Allergan (NYSE: AGN) with a Buy rating and $115.00 price target. In the report, BTIG Research noted, “We are initiating coverage of Allergan Inc. (AGN) with a BUY rating and $115 price target based on 20x 12-24...

In a report published Wednesday, BTIG Research analyst Mark Palmer upgraded the rating on ING US (NYSE: VOYA) from Neutral to Buy, and named a $37.00 price target. In the report, BTIG Research noted, “We are upgrading Voya Financial (VOYA), a.k.a. ING U.S., to BUY (from NEUTRAL) with a price...

In a report published Wednesday, BTIG Research analyst Richard Greenfield upgraded the rating on Facebook (NASDAQ: FB) from Neutral to Buy, and named a $68.00 price target. In the report, BTIG Research noted, “We are upgrading Facebook to BUY from Neutral. Our upgrade is based on the view that...

In a report published Friday, BTIG Research analyst Richard Greenfield upgraded the rating on 21st Century Fox (NASDAQ: FOXA) from Neutral to Buy, and named a $40.00 price target. In the report, BTIG Research noted, “We are upgrading 21st Century to BUY from Neutral and establishing a $40 price...